Skip to main content
MIRA
NASDAQ Life Sciences

MIRA Pharmaceuticals Expands Ketamir-2 IP to 10 Major Markets Ahead of Phase 2a

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1
Mkt Cap
$40.93M
52W Low
$0.9
52W High
$2.45
52W Position info
11% above low
Off High info
59% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MIRA is trading near its 52-week low of $0.9 (11% above the low).

Summary

MIRA Pharmaceuticals has secured worldwide licensing rights for its lead drug candidate, Ketamir-2, expanding its intellectual property to 10 major global markets. This strategic move follows positive Phase 1 results for Ketamir-2 announced on May 13th and precedes its planned Phase 2a development for chemotherapy-induced peripheral neuropathy. The expanded global IP significantly enhances the drug's commercial potential and MIRA's ability to attract strategic partners, which is critical for a company that recently reaffirmed a going concern status. The company is now preparing Phase 2a protocol documentation for FDA submission.

At the time of this announcement, MIRA was trading at $1.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $40.9M. The 52-week trading range was $0.90 to $2.45. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

MIRA - Latest Insights

MIRA
Nov 16, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.6283
Real-time Price: $0.640 info
Change: +$0.0117 (+2%) info
Market Cap: $26.894M info
MIRA
Oct 28, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5561
Real-time Price: $0.640 info
Change: +$0.0839 (+15%) info
Market Cap: $26.894M info
MIRA
Oct 22, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.681
Real-time Price: $0.640 info
Change: -$0.041 (-6%) info
Market Cap: $26.894M info
MIRA
Sep 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.640 info
Change: -$0.0701 (-10%) info
Market Cap: $26.894M info
MIRA
Sep 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.640 info
Change: -$0.0701 (-10%) info
Market Cap: $26.894M info